IDH-wild-type glioblastomas with MMR mutations had higher TMB compared to their MMR-wild-type counterparts (131.9 ± 14.8 vs. 13.6 ± 0.6; P < .0001) (Supplementary Figure 1). This evidence concerns the gene IDH2 and glioblastoma.